Abstract
The large variation of influenza A viruses (IAVs) in various susceptible hosts and their rapid evolution, which allows host/tissue switching, host immune escape, vaccine escape, and drug resistance, are difficult challenges for influenza control in all countries worldwide. Access and binding of the IAV to actual receptors at endocytic sites is critical for the establishment of influenza infection. In this chapter, the progress in identification of and roles of glycans and non-glycans on the epithelium and in the immune system in H1–H18 IAV infections are reviewed. The first part of the review is on current knowledge of H1–H16 IAV receptors on the epithelium including sialyl glycans, other negatively charged glycans, and annexins. The second part of the review focuses on H1–H16 IAV receptors in the immune system including acidic surfactant phospholipids, Sia on surfactant proteins, the carbohydrate recognition domain (CRD) of surfactant proteins, Sia on mucins, Sia and C-type lectins on macrophages and dendritic cells, and Sia on NK cells. The third part of the review is about a possible H17–H18 IAV receptor. Binding of these receptors to IAVs may result in inhibition or enhancement of IAV infection depending on their location, host cell type, and IAV strain. Among these receptors, host sialyl glycans are key determinants of viral hemagglutinin (HA) lectins for H1–H16 infections. HA must acquire mutations to bind to sialyl glycans that are dominant on a new target tissue when switching to a new host for efficient transmission and to bind to long sialyl glycans found in the case of seasonal HAs with multiple glycosylation sites as a consequence of immune evasion. Although sialyl receptors/C-type lectins on immune cells are decoy receptors/pathogen recognition receptors for capturing viral HA lectin/glycans protecting HA antigenic sites, some IAV strains do not escape, such as by release with neuraminidase, but hijack these molecules to gain entry and replication in immune cells. An understanding of the virus–host battle tactics at the receptor level might lead to the establishment of novel strategies for effective control of influenza.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
WHO (2021) Influenza update: 22 November 2021, based on data up to 7 November 2021. https://www.who.int/teams/global-influenza-programme/surveillance-and-monitoring/influenza-updates/current-influenza-update
Wu Y, Wu Y, Tefsen B et al (2014) Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol 22:183–191
Fouchier RA, Munster V, Wallensten A et al (2005) Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79:2814–2822
Kandeil A, Gomaa MR, Shehata MM et al (2019) Isolation and characterization of a distinct influenza A virus from Egyptian bats. J Virol 93:e01059-18
Sriwilaijaroen N, Suzuki Y (2014) Molecular basis of a pandemic of avian-type influenza virus. Methods Mol Biol 1200:447–480
Johnson NP, Mueller J (2002) Updating the accounts: global mortality of the 1918-1920 “Spanish” influenza pandemic. Bull Hist Med 76:105–115
Yang L, Zhao X, Li X et al (2020) Case report for human infection with a highly pathogenic avian influenza A(H5N6) virus in Beijing, China 2019. Biosaf Health 2:49–52
Yu D, Xiang G, Zhu W et al (2019) The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019. Euro Surveill 24:1900273
Sun H, Xiao Y, Liu J et al (2020) Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection. Proc Natl Acad Sci U S A 117:17204–17210
OIE (2006) OIE information document on avian influenza vaccination. https://www.oie.int/app/uploads/2013/04/guidelines20on20ai20vaccination.pdf
FAO. Epidemiology of avian influenza. https://www.fao.org/avianflu/en/clinical.html
CDC (2014) What people who raise pigs need to know about influenza (flu). https://www.cdc.gov/flu/swineflu/people-raise-pigs-flu.htm
Tong S, Zhu X, Li Y et al (2013) New world bats harbor diverse influenza A viruses. PLoS Pathog 9:e1003657
Zhu X, Yang H, Guo Z et al (2012) Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site. Proc Natl Acad Sci U S A 109:18903–18908
Tong S, Li Y, Rivailler P et al (2012) A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A 109:4269–4274
Campos ACA, Goes LGB, Moreira-Soto A et al (2019) Bat influenza A(HL18NL11) virus in fruit bats, Brazil. Emerg Infect Dis 25:333–337
Sriwilaijaroen N, Suzuki Y (2012) Molecular basis of the structure and function of H1 hemagglutinin of influenza virus. Proc Jpn Acad Ser B Phys Biol Sci 88:226–249
Kida H, Yanagawa R, Matsuoka Y (1980) Duck influenza lacking evidence of disease signs and immune response. Infect Immun 30:547–553
Karakus U, Thamamongood T, Ciminski K et al (2019) MHC class II proteins mediate cross-species entry of bat influenza viruses. Nature 567:109–112
Giotis ES, Carnell G, Young EF et al (2019) Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor. Nat Microbiol 4:2035–2038
Leyson C, Youk SS, Smith D et al (2019) Pathogenicity and genomic changes of a 2016 European H5N8 highly pathogenic avian influenza virus (clade 2.3.4.4) in experimentally infected mallards and chickens. Virology 537:172–185
Kuiken T, Taubenberger JK (2008) Pathology of human influenza revisited. Vaccine 26(Suppl 4):D59–D66
Gottschalk A (1959) Chemistry of virus receptors. In: Burnet FM, Stanley WM (eds) The viruses: biochemical, biological, and biophysical properties. Academic Press, Inc., New York, pp 51–61
Suzuki Y, Matsunaga M, Matsumoto M (1985) N-acetylneuraminyllactosylceramide, GM3-NeuAc, a new influenza A virus receptor which mediates the adsorption-fusion process of viral infection. Binding specificity of influenza virus A/Aichi/2/68 (H3N2) to membrane-associated GM3 with different molecular species of sialic acid. J Biol Chem 260:1362–1365
Wilson IA, Skehel JJ, Wiley DC (1981) Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289:366–373
Wu NC, Otwinowski J, Thompson AJ et al (2020) Major antigenic site B of human influenza H3N2 viruses has an evolving local fitness landscape. Nat Commun 11:1233
Chandrasekaran A, Srinivasan A, Raman R et al (2008) Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol 26:107–113
Gambaryan AS, Matrosovich TY, Boravleva EY et al (2018) Receptor-binding properties of influenza viruses isolated from gulls. Virology 522:37–45
Suzuki Y, Ito T, Suzuki T et al (2000) Sialic acid species as a determinant of the host range of influenza A viruses. J Virol 74:11825–11831
Iwasaki M, Inoue S, Troy FA (1990) A new sialic acid analogue, 9-O-acetyl-deaminated neuraminic acid, and α2,8-linked O-acetylated poly(N-glycolylneuraminyl) chains in a novel polysialoglycoprotein from salmon eggs. J Biol Chem 265:2596–2602
Inoue S, Lin SL, Chang T et al (1998) Identification of free deaminated sialic acid (2-keto-3-deoxy-D-glycero-D-galacto-nononic acid) in human red blood cells and its elevated expression in fetal cord red blood cells and ovarian cancer cells. J Biol Chem 273:27199–27204
Suzuki Y, Nagao Y, Kato H et al (1986) Human influenza A virus hemagglutinin distinguishes sialyloligosaccharides in membrane-associated gangliosides as its receptor which mediates the adsorption and fusion processes of virus infection. Specificity for oligosaccharides and sialic acids and the sequence to which sialic acid is attached. J Biol Chem 261:17057–17061
Ito T, Suzuki Y, Suzuki T et al (2000) Recognition of N-glycolylneuraminic acid linked to galactose by the α2,3 linkage is associated with intestinal replication of influenza A virus in ducks. J Virol 74:9300–9305
Samraj AN, Pearce OM, Laubli H et al (2015) A red meat-derived glycan promotes inflammation and cancer progression. Proc Natl Acad Sci U S A 112:542–547
Liu Y, Han C, Wang X et al (2009) Influenza A virus receptors in the respiratory and intestinal tracts of pigeons. Avian Pathol 38:263–266
Suzuki T, Horiike G, Yamazaki Y et al (1997) Swine influenza virus strains recognize sialylsugar chains containing the molecular species of sialic acid predominantly present in the swine tracheal epithelium. FEBS Lett 404:192–196
Sriwilaijaroen N, Kondo S, Yagi H et al (2011) N-glycans from porcine trachea and lung: predominant NeuAcα2-6Gal could be a selective pressure for influenza variants in favor of human-type receptor. PLoS One 6:e16302
Sriwilaijaroen N, Nakakita SI, Kondo S et al (2018) N-glycan structures of human alveoli provide insight into influenza A virus infection and pathogenesis. FEBS J 285:1611–1634
Walther T, Karamanska R, Chan RW et al (2013) Glycomic analysis of human respiratory tract tissues and correlation with influenza virus infection. PLoS Pathog 9:e1003223
Bardor M, Nguyen DH, Diaz S et al (2005) Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem 280:4228–4237
Varki A (2009) Multiple changes in sialic acid biology during human evolution. Glycoconj J 26:231–245
Sriwilaijaroen N, Kondo S, Yagi H et al (2012) Bovine milk whey for preparation of natural N-glycans: structural and quantitative analysis. Open Glycosci 5:41–50
Sack A, Cullinane A, Daramragchaa U et al (2019) Equine influenza virus—a neglected, reemergent disease threat. Emerg Infect Dis 25(6):1185–1191
Sriwilaijaroen N, Suzuki Y (2020) Host receptors of influenza viruses and coronaviruses-molecular mechanisms of recognition. Vaccines (Basel) 8:587
Chen LM, Rivailler P, Hossain J et al (2011) Receptor specificity of subtype H1 influenza A viruses isolated from swine and humans in the United States. Virology 412:401–410
Takahashi T, Hashimoto A, Maruyama M et al (2009) Identification of amino acid residues of influenza A virus H3 HA contributing to the recognition of molecular species of sialic acid. FEBS Lett 583:3171–3174
Broszeit F, Tzarum N, Zhu X et al (2019) N-glycolylneuraminic acid as a receptor for influenza A viruses. Cell Rep 27:3284–3294.e3286
Sriwilaijaroen N, Suzuki Y (2020) Sialoglycovirology of lectins: sialyl glycan binding of enveloped and non-enveloped viruses. Methods Mol Biol 2132:483–545
Sriwilaijaroen N, Suzuki K, Takashita E et al (2015) 6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential. J Antimicrob Chemother 70:2797–2809
Gao R, Pan M, Li X et al (2016) Post-mortem findings in a patient with avian influenza A (H5N6) virus infection. Clin Microbiol Infect 22(574):e571–e575
Wu W, Air GM (2004) Binding of influenza viruses to sialic acids: reassortant viruses with A/NWS/33 hemagglutinin bind to α2,8-linked sialic acid. Virology 325:340–350
Childs RA, Palma AS, Wharton S et al (2009) Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol 27:797–799
Matrosovich M, Stech J, Klenk HD (2009) Influenza receptors, polymerase and host range. Rev Sci Tech 28:203–217
Suzuki Y, Matsunaga M, Nagao Y et al (1985) Ganglioside GM1b as an influenza virus receptor. Vaccine 3:201–203
Gambaryan A, Yamnikova S, Lvov D et al (2005) Receptor specificity of influenza viruses from birds and mammals: new data on involvement of the inner fragments of the carbohydrate chain. Virology 334:276–283
Suzuki Y, Nakao T, Ito T et al (1992) Structural determination of gangliosides that bind to influenza A, B, and C viruses by an improved binding assay: strain-specific receptor epitopes in sialo-sugar chains. Virology 189:121–131
Ogata M, Murata T, Murakami K et al (2007) Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a gamma-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses. Bioorg Med Chem 15:1383–1393
Hiono T, Okamatsu M, Igarashi M et al (2016) Amino acid residues at positions 222 and 227 of the hemagglutinin together with the neuraminidase determine binding of H5 avian influenza viruses to sialyl Lewis X. Arch Virol 161:307–316
Guo CT, Takahashi N, Yagi H et al (2007) The quail and chicken intestine have sialyl-galactose sugar chains responsible for the binding of influenza A viruses to human type receptors. Glycobiology 17:713–724
Sriwilaijaroen N, Kondo S, Yagi H et al (2009) Analysis of N-glycans in embryonated chicken egg chorioallantoic and amniotic cells responsible for binding and adaptation of human and avian influenza viruses. Glycoconj J 26:433–443
Hiono T, Okamatsu M, Nishihara S et al (2014) A chicken influenza virus recognizes fucosylated α2,3 sialoglycan receptors on the epithelial cells lining upper respiratory tracts of chickens. Virology 456–457:131–138
Lin YP, Xiong X, Wharton SA et al (2012) Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc Natl Acad Sci U S A 109:21474–21479
Yang H, Carney P, Stevens J (2010) Structure and receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr 2:RRN1152
Gulati S, Smith DF, Cummings RD et al (2013) Human H3N2 influenza viruses isolated from 1968 to 2012 show varying preference for receptor substructures with no apparent consequences for disease or spread. PLoS One 8:e66325
Kuiken T, Fouchier R, Rimmelzwaan G et al (2011) Pigs, poultry, and pandemic influenza: how zoonotic pathogens threaten human health. Adv Exp Med Biol 719:59–66
WHO (2009) Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. http://who.int/csr/resources/publications/swineflu/clinical_management_h1n1.pdf
Shieh WJ, Blau DM, Denison AM et al (2010) 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 177:166–175
Chu VC, Whittaker GR (2004) Influenza virus entry and infection require host cell N-linked glycoprotein. Proc Natl Acad Sci U S A 101:18153–18158
de Vries E, de Vries RP, Wienholts MJ et al (2012) Influenza A virus entry into cells lacking sialylated N-glycans. Proc Natl Acad Sci U S A 109:7457–7462
Fujioka Y, Nishide S, Ose T et al (2018) A sialylated voltage-dependent Ca2+ channel binds hemagglutinin and mediates influenza A virus entry into mammalian cells. Cell Host Microbe 23:809–818.e805
Eierhoff T, Hrincius ER, Rescher U et al (2010) The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog 6:e1001099
Chan CM, Chu H, Zhang AJ et al (2016) Hemagglutinin of influenza A virus binds specifically to cell surface nucleolin and plays a role in virus internalization. Virology 494:78–88
Upham JP, Pickett D, Irimura T et al (2010) Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry. J Virol 84:3730–3737
Mao H, Tu W, Qin G et al (2009) Influenza virus directly infects human natural killer cells and induces cell apoptosis. J Virol 83:9215–9222
Rapoport EM, Mochalova LV, Gabius HJ et al (2006) Search for additional influenza virus to cell interactions. Glycoconj J 23:115–125
Byrd-Leotis L, Jia N, Dutta S et al (2019) Influenza binds phosphorylated glycans from human lung. Sci Adv 5:eaav2554
Otto M, Gunther A, Fan H et al (1994) Identification of annexin 33 kDa in cultured cells as a binding protein of influenza viruses. FEBS Lett 356:125–129
Huang RT, Lichtenberg B, Rick O (1996) Involvement of annexin V in the entry of influenza viruses and role of phospholipids in infection. FEBS Lett 392:59–62
Arora S, Lim W, Bist P et al (2016) Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosis. Cell Death Differ 23:1243–1256
Guo CT, Ohta S, Yoshimoto A et al (2001) A unique phosphatidylinositol bearing a novel branched-chain fatty acid from Rhodococcus equi binds to influenza virus hemagglutinin and inhibits the infection of cells. J Biochem 130:377–384
Numata M, Mitchell JR, Tipper JL et al (2020) Pulmonary surfactant lipids inhibit infections with the pandemic H1N1 influenza virus in several animal models. J Biol Chem 295:1704–1715
Veldhuizen R, Nag K, Orgeig S et al (1998) The role of lipids in pulmonary surfactant. Biochim Biophys Acta 1408:90–108
Svane-Knudsen V, Rasmussen G, Clausen PP (1990) Surfactant-like lamellar bodies in the mucosa of the human nose. Acta Otolaryngol 109:307–313
Schlosser RJ (2006) Surfactant and its role in chronic sinusitis. Ann Otol Rhinol Laryngol Suppl 196:40–44
Parra E, Perez-Gil J (2015) Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films. Chem Phys Lipids 185:153–175
Haagsman HP (1998) Interactions of surfactant protein A with pathogens. Biochim Biophys Acta 1408:264–277
Guagliardo R, Perez-Gil J, De Smedt S et al (2018) Pulmonary surfactant and drug delivery: focusing on the role of surfactant proteins. J Control Release 291:116–126
Goss KL, Kumar AR, Snyder JM (1998) SP-A2 gene expression in human fetal lung airways. Am J Respir Cell Mol Biol 19:613–621
Kim JK, Kim SS, Rha KW et al (2007) Expression and localization of surfactant proteins in human nasal epithelium. Am J Physiol Lung Cell Mol Physiol 292:L879–L884
Gaunsbaek MQ, Kjeldsen AD, Svane-Knudsen V et al (2014) Surfactant proteins A, B, C and D in the human nasal airway: associated with mucosal glands and ciliated epithelium but absent in fluid-phase secretions and mucus. ORL J Otorhinolaryngol Relat Spec 76:288–301
van Eijk M, White MR, Batenburg JJ et al (2004) Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. Am J Respir Cell Mol Biol 30:871–879
Mikerov AN, White M, Hartshorn K et al (2008) Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells. Med Microbiol Immunol 197:9–12
Benne CA, Kraaijeveld CA, van Strijp JA et al (1995) Interactions of surfactant protein A with influenza A viruses: binding and neutralization. J Infect Dis 171:335–341
van Eijk M, White MR, Crouch EC et al (2003) Porcine pulmonary collectins show distinct interactions with influenza A viruses: role of the N-linked oligosaccharides in the carbohydrate recognition domain. J Immunol 171:1431–1440
van Eijk M, Rynkiewicz MJ, Khatri K et al (2018) Lectin-mediated binding and sialoglycans of porcine surfactant protein D synergistically neutralize influenza A virus. J Biol Chem 293:10646–10662
Sriwilaijaroen N, Suzuki Y (2020) Hemagglutinin inhibitors are potential future anti-influenza drugs for mono- and combination therapies. Methods Mol Biol 2132:547–565
Hartshorn KL, White MR, Voelker DR et al (2000) Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem J 351(Pt 2):449–458
Hartshorn KL, Webby R, White MR et al (2008) Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D. Respir Res 9:65
Suzuki Y (2005) Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull 28:399–408
Malhotra R, Haurum JS, Thiel S et al (1994) Binding of human collectins (SP-A and MBP) to influenza virus. Biochem J 304(Pt 2):455–461
Al-Qahtani AA, Murugaiah V, Bashir HA et al (2019) Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: a recombinant form containing neck and lectin domains promotes infectivity. Immunobiology 224:408–418
LeVine AM, Whitsett JA, Hartshorn KL et al (2001) Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 167:5868–5873
Benne CA, Benaissa-Trouw B, van Strijp JA et al (1997) Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages. Eur J Immunol 27:886–890
Rose MC, Voynow JA (2006) Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86:245–278
O’Riordan N, Kane M, Joshi L et al (2014) Structural and functional characteristics of bovine milk protein glycosylation. Glycobiology 24:220–236
Parry S, Hanisch FG, Leir SH et al (2006) N-Glycosylation of the MUC1 mucin in epithelial cells and secretions. Glycobiology 16:623–634
Taniguchi T, Woodward AM, Magnelli P et al (2017) N-Glycosylation affects the stability and barrier function of the MUC16 mucin. J Biol Chem 292:11079–11090
Kim J, Lee J, Jang Y et al (2019) N-Glycans of bovine submaxillary mucin contain core-fucosylated and sulfated glycans but not sialylated glycans. Int J Biol Macromol 138:1072–1078
Zanin M, Baviskar P, Webster R et al (2016) The interaction between respiratory pathogens and mucus. Cell Host Microbe 19:159–168
Yang X, Steukers L, Forier K et al (2014) A beneficiary role for neuraminidase in influenza virus penetration through the respiratory mucus. PLoS One 9:e110026
Matrosovich MN, Matrosovich TY, Gray T et al (2004) Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol 78:12665–12667
Cohen M, Zhang XQ, Senaati HP et al (2013) Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase. Virol J 10:321
Barbier D, Garcia-Verdugo I, Pothlichet J et al (2012) Influenza A induces the major secreted airway mucin MUC5AC in a protease-EGFR-extracellular regulated kinase-Sp1-dependent pathway. Am J Respir Cell Mol Biol 47:149–157
Ehre C, Worthington EN, Liesman RM et al (2012) Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs. Proc Natl Acad Sci U S A 109:16528–16533
Kesimer M, Scull M, Brighton B et al (2009) Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J 23:1858–1868
McAuley JL, Corcilius L, Tan HX et al (2017) The cell surface mucin MUC1 limits the severity of influenza A virus infection. Mucosal Immunol 10:1581–1593
Verhagen JH, Eriksson P, Leijten L et al (2021) Host range of influenza A virus H1 to H16 in Eurasian ducks based on tissue and receptor binding studies. J Virol 95:e01873-01820
Delaveris CS, Webster ER, Banik SM et al (2020) Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus. Proc Natl Acad Sci U S A 117:12643–12650
Short KR, Brooks AG, Reading PC et al (2012) The fate of influenza A virus after infection of human macrophages and dendritic cells. J Gen Virol 93:2315–2325
Ng WC, Liong S, Tate MD et al (2014) The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus. J Virol 88:1659–1672
Hillaire ML, Nieuwkoop NJ, Boon AC et al (2013) Binding of DC-SIGN to the hemagglutinin of influenza A viruses supports virus replication in DC-SIGN expressing cells. PLoS One 8:e56164
Ng WC, Londrigan SL, Nasr N et al (2016) The C-type lectin langerin functions as a receptor for attachment and infectious entry of influenza A virus. J Virol 90:206–221
Gillespie L, Roosendahl P, Ng WC et al (2016) Endocytic function is critical for influenza A virus infection via DC-SIGN and L-SIGN. Sci Rep 6:19428
Marvin SA, Russier M, Huerta CT et al (2017) Influenza virus overcomes cellular blocks to productively replicate, impacting macrophage function. J Virol 91:e01417-01416
Sakabe S, Iwatsuki-Horimoto K, Takano R et al (2011) Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses. J Gen Virol 92:1428–1434
Yu WC, Chan RW, Wang J et al (2011) Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. J Virol 85:6844–6855
van Riel D, Leijten LM, van der Eerden M et al (2011) Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction. PLoS Pathog 7:e1002099
Sun S, Wang Q, Zhao F et al (2011) Glycosylation site alteration in the evolution of influenza A (H1N1) viruses. PLoS One 6:e22844
Cline TD, Karlsson EA, Seufzer BJ et al (2013) The hemagglutinin protein of highly pathogenic H5N1 influenza viruses overcomes an early block in the replication cycle to promote productive replication in macrophages. J Virol 87:1411–1419
Friesenhagen J, Boergeling Y, Hrincius E et al (2012) Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophages. J Leukoc Biol 92:11–20
Bender A, Albert M, Reddy A et al (1998) The distinctive features of influenza virus infection of dendritic cells. Immunobiology 198:552–567
Osterlund P, Pirhonen J, Ikonen N et al (2010) Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol 84:1414–1422
Perrone LA, Plowden JK, Garcia-Sastre A et al (2008) H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4:e1000115
Thitithanyanont A, Engering A, Ekchariyawat P et al (2007) High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands. J Immunol 179:5220–5227
Smed-Sorensen A, Chalouni C, Chatterjee B et al (2012) Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells. PLoS Pathog 8:e1002572
Cella M, Salio M, Sakakibara Y et al (1999) Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 189:821–829
van Vliet SJ, van Liempt E, Geijtenbeek TB et al (2006) Differential regulation of C-type lectin expression on tolerogenic dendritic cell subsets. Immunobiology 211:577–585
Jegaskanda S, Vanderven HA, Tan HX et al (2019) Influenza virus infection enhances antibody-mediated NK cell functions via type I interferon-dependent pathways. J Virol 93:e02090-02018
Mandelboim O, Lieberman N, Lev M et al (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409:1055–1060
Arnon TI, Lev M, Katz G et al (2001) Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 31:2680–2689
Ophir Y, Duev-Cohen A, Yamin R et al (2016) PILRalpha binds an unknown receptor expressed primarily on CD56bright and decidual-NK cells and activates NK cell functions. Oncotarget 7:40953–40964
Arnon TI, Achdout H, Lieberman N et al (2004) The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 103:664–672
Bar-On Y, Glasner A, Meningher T et al (2013) Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses. Cell Rep 3:1044–1050
Rosenstock P, Bork K, Massa C et al (2020) Sialylation of human natural killer (NK) cells is regulated by IL-2. J Clin Med 9:1816
Guo H, Kumar P, Moran TM et al (2009) The functional impairment of natural killer cells during influenza virus infection. Immunol Cell Biol 87:579–589
Mao H, Liu Y, Sia SF et al (2017) Avian influenza virus directly infects human natural killer cells and inhibits cell activity. Virol Sin 32:122–129
Karakus U, Pohl MO, Stertz S (2020) Breaking the convention: sialoglycan variants, coreceptors, and alternative receptors for influenza A virus entry. J Virol 94:e01357-19
Maruyama J, Nao N, Miyamoto H et al (2016) Characterization of the glycoproteins of bat-derived influenza viruses. Virology 488:43–50
Ciminski K, Ran W, Gorka M et al (2019) Bat influenza viruses transmit among bats but are poorly adapted to non-bat species. Nat Microbiol 4:2298–2309
Fujioka Y, Tsuda M, Nanbo A et al (2013) A Ca2+-dependent signalling circuit regulates influenza A virus internalization and infection. Nat Commun 4:2763
Banerjee A, Mossman KL, Miller MS (2020) Bat influenza viruses: making a double agent of MHC class II. Trends Microbiol 28:703–706
Peng W, de Vries RP, Grant OC et al (2017) Recent H3N2 viruses have evolved specificity for extended, branched human-type receptors, conferring potential for increased avidity. Cell Host Microbe 21:23–34
Klein A, Carnoy C, Wieruszeski JM et al (1992) The broad diversity of neutral and sialylated oligosaccharides derived from human salivary mucins. Biochemistry 31:6152–6165
Gerken TA, Jentoft N (1987) Structure and dynamics of porcine submaxillary mucin as determined by natural abundance carbon-13 NMR spectroscopy. Biochemistry 26:4689–4699
Stray SJ, Pittman LB (2012) Subtype- and antigenic site-specific differences in biophysical influences on evolution of influenza virus hemagglutinin. Virol J 9:91
de Vries E, Du W, Guo H et al (2020) Influenza A virus hemagglutinin-neuraminidase-receptor balance: preserving virus motility. Trends Microbiol 28:57–67
Lambertz RLO, Pippel J, Gerhauser I et al (2018) Exchange of amino acids in the H1-haemagglutinin to H3 residues is required for efficient influenza A virus replication and pathology in Tmprss2 knock-out mice. J Gen Virol 99:1187–1198
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Sriwilaijaroen, N., Suzuki, Y. (2022). Roles of Glycans and Non-glycans on the Epithelium and in the Immune System in H1–H18 Influenza A Virus Infections. In: Suzuki, Y. (eds) Glycovirology. Methods in Molecular Biology, vol 2556. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2635-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2635-1_16
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2634-4
Online ISBN: 978-1-0716-2635-1
eBook Packages: Springer Protocols